Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Science & Technology Holdings specializes in the commercialization of technologies developed by government-funded research institutions in South Korea. The company provides financing for startups and incubates future growth drivers of established companies across various sectors including but not limited to life sciences. It acts as a bridge between public R&D and private sector commercialization. The company has made at least 45 investments with one known portfolio exit as of late 2024. Its activities are central to South Korea’s national strategy to promote innovation-driven economic growth. While it supports many health/life science ventures through investment and incubation, it itself does not conduct drug discovery or development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Science & Technology Holdings.